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Abstract 
 
Selective autophagic degradation of cellular components underlies many of the important 
physiological and pathological implications that autophagy has in mammalian cells.  
Cytoplasmic vesicles, just like other intracellular items, can be subjected to conventional 
autophagic events where double-membrane autophagosomes specifically isolate and deliver 
them for lysosomal destruction.  However, intracellular membranes appear to constitute 
common platforms for unconventional versions of the autophagic pathway, a notion that 
has become apparent during the last few years.  For instance, in many cases of autophagy 
directed against bacterial phagosomes, subversion of the process results in multimembrane 
vacuoles that promote bacterial replication instead of the usual degradative outcome.  In a 
different atypical modality, single-membrane vesicles can be labeled with LC3 to direct 
their contents for lysosomal degradation.  In fact, single-membrane compartments of 
various kinds often provide an assembly site to the autophagic machinery for unanticipated 
non-degradative activities that range from localized secretion of lysosomal contents to 
melanosome function.  Interestingly, many of these unconventional processes seem to be 
initiated through engagement of relevant nodes of the autophagic signaling network that, 
once activated, promote LC3 decoration of the targeted membrane, and some cases of 
inducer/adaptor proteins that specifically engage those important signaling hubs have 
recently been described.  Here we review the available examples of all autophagic variants 
involving membranous compartments, with a main focus on the more recently discovered 
unconventional phenomena where the usual degradation purpose of autophagy or its 
canonical mechanistic features are not completely conserved.   
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Autophagy  
 
Macroautophagy (generally referred to as autophagy) is a complex cellular route that 
promotes the regulated degradation of cytoplasmic components and is highly conserved in 
all eukaryotic organisms.1,2  The molecular pathway that controls autophagy has been well 
studied in yeast,3 and the relevance that this phenomenon has in a wide variety of human 
pathophysiological processes has fueled its detailed analysis also in mammalian systems.4-6  
This route involves cargo isolation into canonical double-membrane vesicles called 
autophagosomes, which in essence constitute sacs of disposable elements that eventually 
fuse with lysosomes to degrade their contents.7  Therefore, autophagy at the minimum must 
involve the action of molecular machinery that promotes isolation of the item targeted for 
destruction and also mechanisms to label the final garbage bag for fusion with the 
lysosomal compartment.   
Autophagy was initially characterized as an adaptive response to starvation.4  In this 
biological context, it mainly acts to obtain basic constituents from random cytoplasmic 
components, thus redirecting nutrients to feed essential metabolic pathways.8,9  However, 
the autophagic process is rapidly upregulated as a common adaptation response to a variety 
of stressful situations, not only starvation.10  In a number of these conditions, like organelle 
malfunction, genotoxic stress or the presence of foreign invaders, autophagy functions as a 
degradation mechanism for specific, obsolete or potentially harmful components, 
irrespective of the recycling consequences of the process.11,12  Autophagic destruction also 
plays critical housekeeping roles by proceeding at a low, constitutive level under basal 
conditions, a situation where it also acts with some degree of specificity by removing long-
lived proteins as well as superfluous or damaged organelles.11  Therefore, although 
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traditionally thought to be a fairly unspecific process that responds to the lack of nutrients, 
it is now known that autophagy can target specific cellular items for timely degradation.  
 
Autophagic machinery 
 
Early work in yeast has facilitated discovery of the core molecular machinery involved in 
the autophagic response to starvation, a collection of molecules known as Autophagy-
related genes or Atgs.2,13,14  Subsequent work in higher eukaryotes has led to identification 
of many Atg orthologs, thus producing a relatively clear picture of how autophagy is 
regulated in mammalian cells.4  Briefly, a protein complex containing ULK1/ATG1-
MTOR-ATG13-RB1CC1/FIP200 senses starvation or stress signals and derepresses the 
autophagic process that is downregulated by constitutively active MTOR.  In a process not 
fully understood, this complex promotes the translocation of a second molecular complex 
including class III phosphatidylinositol 3-kinase/PIK3C3/VPS34-BECN1/Beclin 1/ATG6-
ATG14 to the endoplasmic reticulum (ER) where it generates phosphatidylinositol 3-
phosphate/PtdIns3P, an uncommon lipid in this compartment.14  The local presence of 
PtdIns3P initiates autophagosome nucleation through formation of prototypical ER-
associated structures called cradles or omegasomes,15,16 a phenomenon that may involve 
PtdIns3P-binding proteins like members of the WIPI family or ZFYVE1/DFCP1.17,18  The 
ER itself likely acts as a membrane source in this case, but other organelles like 
mitochondria,19 mitochondrial associated membranes20 or the plasma membrane21 have also 
been suggested as membrane donors for autophagosome formation.7,22.   
Following these initiating events, membrane elongation and autophagosome closure 
are driven by two ubiquitin-like modification systems that promote the covalent addition of 
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phosphatidylethanolamine (PE) to LC3/ATG8, thus producing a membrane-bound form 
named LC3-II.2,23  In these conjugation systems ATG12 and LC3 behave as ubiquitin-like 
modifiers, and ATG7 separately acts as an E1 enzyme for both molecules.  In the next step, 
ATG10 functions as the E2 enzyme for the subsequent formation of an ATG12-ATG5 
covalent complex in the absence of a proper E3 conjugation system, whereas ATG3 
behaves as an E2 module for LC3.  ATG12-ATG5 then binds oligomerized ATG16L1 (the 
mammalian ortholog of yeast Atg16) to assemble a final E3 system for the conjugation of 
PE to the pool of LC3 brought to the vicinity through interaction between ATG3-LC3 and 
ATG12.24  Interestingly, whereas the ATG12-ATG5 complex suffices for this E3-ligase 
activity,25 ATG16L1 is known to define the site for LC3-II generation.24 
LC3 associates with the autophagosomal compartment at all stages of the process, 
and therefore it is used as the major autophagic reporter system.26  However, its precise 
molecular function is still unclear.  Although most of the available mechanistic information 
has been obtained by studying LC3B, a total of eight LC3 or LC3-like homologues are 
known to exist: LC3A (which includes two splicing isoforms), LC3B, LC3C, GABARAP, 
GABARAPL1, GABARAPL2 and GABARAPL3.  It has been clearly established that LC3 
lipidation is essential for elongation of the autophagosomal membrane and its final 
closure,27,28 probably owing to the ability of the family to mediate membrane fusion 
events.29,30  Notably, the GABARAP subgroup seems to mainly function in autophagosome 
maturation.31  However, since LC3 was originally discovered as a microtubule-associated 
protein,32 a role for this family in directing the mature autophagosomes to fusion with the 
lysosomes through the cytoskeletal tracks has been invoked.23  In addition, LC3 labeling of 
both canonical autophagosomes and single-membrane vesicles has been proposed to 
directly facilitate fusion with the lysosome,33,34 a function that might have been overlooked 
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due to the critical upstream activity that LC3 has in autophagosome formation and 
maturation.  This possible involvement in lysosomal fusion could explain why certain non-
autophagosomal compartments (phagosomes or endosomes, for example) are targeted to 
the lysosome more efficiently when becoming coated with LC3.35,36  However, definitive 
proof for any of these alternative activities is still missing.  Whatever the case, LC3 
labeling seems to be the end point event that commits a given vesicle to fusion with the 
lysosomal compartment.  This notion may be more clearly illustrated by unconventional 
autophagic processes where LC3 mediates non-degradative activities that still involve 
lysosomal targeting, like the extracellular secretion of lysosomal contents required for bone 
resorption (see below).   
Although the fundamental molecular mechanisms involved in autophagosome 
formation and maturation in mammalian cells have been reasonably well described, 
important issues remain to be clarified.  For example, a full consensus is yet to be reached 
regarding the main membrane source for autophagosome generation and whether or not 
different compartments act as membrane donors depending on the initial autophagic 
stimulus.  Mechanistically, how exactly the preinitiation complexes containing ULK1 and 
BECN1 interact to initiate autophagosome formation, the role of the PtdIns3P-binding 
proteins WIPI and ZFYVE1 in this process, how the two ubiquitin-like protein 
modification cascades that culminate with LC3-II synthesis promote membrane elongation 
and final autophagosomal closure, and whether or not there are autophagy-specific 
mechanisms that promote fusion of the mature autophagosome with the lysosome (and the 
role of LC3 in this process), are key issues still waiting to be fully resolved.   
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Functions of autophagy and relevance of selective autophagy 
 
Judging from the phenotypes of Atg-deficient mice, the autophagic process has wide 
implications in a number of physiological and pathological processes, including tumor 
suppression, neurodegeneration, inflammation and native and adaptive immunity.11,37,38  
For example, absence of BECN1 or ATG4 increases susceptibility to tumorigenesis,39-41 
likely because these animals are unable to fight the deleterious effects of cellular stress.42  
Brain specific deletion of Atg5 or Atg7 provokes early neurodegeneration caused by 
accumulation of insoluble protein aggregates.43,44  Absence of ATG16L1 causes an 
intestinal inflammatory phenotype that resembles Crohn’s disease,45-47 an observation that 
correlates well with the existence of a human ATG16L1 allele that increases susceptibility 
to this pathology.48-50  Other roles include participation in developmental processes,51 or in 
adaptive immunity by promoting efficient antigen presentation.52  Autophagy also 
constitutes an innate mechanism that helps fight intracellular pathogens, like viruses and 
bacteria.53  
Interestingly, selective autophagy has a relevant role in many of these phenotypes, 
and therefore is nowadays a matter of active investigation.  For example, the cancer 
susceptibility phenotype might be due to poor elimination of damaged organelles and the 
consequent overproduction of pro-inflammatory and DNA-damaging reactive oxygen 
species.54-56  Neurodegeneration in Atg-deficient mice is mediated by the toxic effects of 
protein precipitates that are selectively targeted to the autophagic pathway in normal 
conditions.57,58  Elimination of foreign invaders also involves their specific recognition by 
the autophagic machinery, whether they are loose in the cytoplasm 59,60 or enclosed in 
conventional phagosomes.35,61   
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Mechanistically, these different modalities of selective autophagy seem to be 
executed through the action of inducer or adaptor proteins that link the item targeted for 
destruction with certain nodes of the core autophagic machinery with the apparent final 
purpose of promoting LC3 labeling of the selected cargo.  One of these nodes seems to be 
LC3 itself (Fig. 1).  Thus, both insoluble protein precipitates and cytosolic bacteria become 
heavily ubiquitinated, and adaptor proteins able to simultaneously bind ubiquitin and LC3 
target them for autophagic degradation.62  NBR1,63 p62/SQSTM1,64 CALCOCO2/NDP5265 
and OPTINEURIN66 are examples of these adaptors.  In addition, damaged or obsolete 
mitochondria become ubiquitinated by the E3-ligase PARK2/PARKIN that is recruited to 
the target organelle by PINK1,67-69 a kinase that becomes stabilized in damaged 
mitochondria and thus promotes PARK2-mediated ubiquitination of a wide array of 
mitochondrial proteins.70  The labeled mitochondria are then recognized by p62/SQSTM1 
for autophagic delivery.71  Depolarized mitochondria can also be directed to autophagic 
destruction by recruiting NIX, a Bcl2-family protein able to bind LC3 thus acting as an 
adaptor module.72  In all these cases, interaction between the adaptors and LC3 is mediated 
by a common LC3-interacting motif (LIR), whether it is the canonical signature (WXXL)73 
or an atypical motif recognized by LC3C.74  Other examples of autophagic signaling nodes 
that are engaged (either directly or indirectly) by specific inducers are the BECN1-PIK3C3 
and ATG12-ATG5-ATG16L1 complexes (Fig. 1).  Evidence supporting such roles is 
provided throughout this review.  
 
Selective autophagy against membrane compartments with canonical degradation 
purposes 
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Membrane-bound intracellular organelles can be subjected to conventional autophagic 
processes where regular autophagosomes form around them (or fuse with them) thus 
producing multimembrane vesicles destined to lysosomal destruction (Fig. 2A).  For 
instance, phagosomes whose natural maturation pathway is stalled by Mycobacteria are 
targeted by regular autophagosomal compartments that fuse with the bacteria-containing 
sac, an autophagic response that suppresses survival of the invader.61  A similar 
phenomenon involving multiple-membrane vesicular structures targets the Salmonella-
containing vacuole in epithelial cells, thus inhibiting bacterial replication.  An atypical 
route is involved here, since this process shows independency of the classical mediators 
PIK3C3, RB1CC1 and ATG9.75  As mentioned above, damaged mitochondria can also be 
eliminated by canonical autophagy mediated by ubiquitination.  Stressed portions of the 
endoplasmic reticulum are degraded in regular autophagosomes containing lamellar 
structures that stain positive for reticular markers.76,77 Similarly, excess peroxisomes78 or 
damaged lysosomes79 in mammalian cells are cleared through an autophagic process that 
encloses these organelles into double membrane autophagosomes. 
 However, while autophagic targeting of conventional cytoplasmic substrates needs 
formation of a membranous compartment that isolates the doomed item, autophagy against 
the contents of a vesicular structure could conceivably spare cargo isolation and rely only 
on LC3 labeling of an already existing vacuole.  In fact, some recently described examples 
support this novel idea (Fig. 2B).  In the following we review the new developments on this 
topic. 
Phagosomes containing stimulated TOLL-like receptor (TLR) 2 become rapidly 
decorated with BECN1 to promote LC3 labeling of this non-autophagic single-membrane 
compartment, a process that promotes more efficient acquisition of lysosomal features.35  
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This phenomenon has been called LC3-associated phagocytosis (LAP) and it has since been 
observed in different settings, including engulfment of dead cells,80 phagocytosis of 
Burkholderia pseudomallei,81 stimulation of phagosomal Fcγ-Receptors,82 efficient 
formation of phagosomal IRF7-signaling compartments in response to TLR9 stimulation by 
DNA immune complexes,83 circadian degradation of phagocytosed photoreceptors by 
retinal pigment epithelial cells,84 or various phagocytic phenomena in dendritic cells that 
favor presentation of MHC-II-restricted antigens.52  However, the notion that certain TLRs 
activate autophagy to fight intracellular invaders has also been linked to the induction of 
general autophagy.61,85,86  Therefore, some controversy has arisen as to whether LAP could 
in fact involve distant generation of autophagosomes through the regular route followed by 
a quick fusion event with the phagosome.  This possibility could explain why induction of 
general autophagy might have some of the beneficial effects of selective autophagy in this 
context, as it has been previously noted.10  However, translocation of BECN1 to the 
phagosome and labeling with LC3 are extremely rapid events in LAP, and no evidence of 
multiple membranes was detected.35  These observations argue against the fusion model 
and favor the involvement of an in situ LC3-II synthesis event.  Still, unequivocally ruling 
out that activated TLR2 first induces formation of canonical autophagosomes that then 
rapidly fuse with the targeted phagosome may not be easy.  Perhaps the most convincing 
evidence is that LAP proceeds independently of some of the initiating autophagic 
machinery (ULK1)80 and so it seems mechanistically different from other examples where 
stimulation of general autophagy (which does involve ULK1) has antibacterial effects.61  It 
is entirely possible, however, that both autophagic mechanisms contribute to the same goal 
in this physiological context.  
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In any case, the notion that LC3-II can be synthesized in situ to label single 
membrane structures has been raised again in other experimental systems where different 
inducer molecules act by directly engaging ATG16L1.  As mentioned above, ATG16L1 
defines the site of LC3 lipidation by bringing both LC3 and the LC3-II-synthesis complex 
(ATG12-ATG5 and ATG3-LC3) close to a membrane source,24 so it is conceivable that 
ATG16L1 may have a relevant role in autophagy directed to membranous compartments.  
Thus, ATG16L1 might constitute an additional node for selective autophagy with a 
particularly important function in autophagy directed against intracellular membranes.  In 
fact, the existence of specific factors that recruit ATG16L1 to the proper sites for LC3-II 
synthesis has been suggested before.14,24,75  Examples of such factors have recently become 
available.   
For instance, the native immune receptors NOD1 and 2 recognize bacteria 
(Shigella) at the entry site and engage ATG16L1 to promote LC3 labeling of the nascent 
phagosome.87  Although it is unclear if acquisition of LC3 in this context results from 
fusion with preexisting autophagosomes or from local LC3-II synthesis, NODs probably 
constitute the first description of an ATG16L1 adaptor molecule (Fig. 1).  In an additional 
example, it has recently been described that the transmembrane molecule TMEM59 holds a 
minimal 19-aminoacid stretch in its intracellular domain that promotes LC3 labeling of the 
same single membrane endosomes where the peptide becomes activated by aggregation.36  
This minimal peptide can be reduced to a four-aminoacid motif whose integrity is 
necessary for the activity.  The LC3-labeled endosomes undergo more efficient lysosomal 
degradation of their contents, thus recapitulating some of the main functional consequences 
of LAP.  Mechanistically, the active peptide interacts with ATG16L1 through the minimal 
motif, suggesting that TMEM59 may be another example of an ATG16L1 adaptor involved 
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in selective autophagy against single-membrane vesicular compartments (Fig. 1).  Again, 
distinguishing between mechanisms involving fusion with canonical autophagic vesicles 
versus local LC3 lipidation was a relevant issue.  The LC3-labeled vesicles did not show 
evidence of multiple membranes and appeared devoid of cellular material in EM studies, 
suggesting that they did not undergo fusion events with preexisting autophagosomes to 
become LC3-positive.  Consistent with this, there was a very tight colocalization between 
GFP-LC3 and endocytosed TMEM59, and distal formation of autophagosomes in response 
to TMEM59 activation was not detected.  The process relies on the canonical autophagic 
effectors ATG5 and ATG7,36 but appears to proceed independently of BECN1 (Pimentel-
Muiños’ laboratory, unpublished observations), arguing that TMEM59 bypasses the 
upstream autophagic machinery, just like LAP does at a different level.  From a 
mechanistic point of view, this independence of upstream activators is the logical 
consequence of directly engaging ATG16L1 and, with it, the LC3-II synthesis machinery 
(ATG12-ATG5 and ATG3-LC3) that is normally assembled with ATG16L1 in a 
macromolecular complex.88  Proximity between this machinery and a membrane source 
would favor local (in situ) lipidation of LC3 and, therefore, LC3 labeling of the same 
vesicle where activation of TMEM59 takes place.   
In an effort to evaluate a possible interaction of TMEM59 with the canonical 
autophagic pathway, the authors tested if TMEM59 overexpression (or forced aggregation 
of chimeric transmembrane molecules) was able to influence the clearance rate of 
established autophagic substrates like p62/SQSTM1, NBR1 or insoluble protein 
precipitates formed by the pathological form of huntingtin (Q74).  The rationale here is that 
any possible intersection with the conventional route should result in altered levels of 
molecules that are normally cleared through the same pathway.  While TMEM59 activation 
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provoked substantial LC3-II accumulation, it did not alter at all the levels of these 
substrates, indicating that TMEM59 neither blocks nor accelerates the canonical autophagic 
flux.  This is actually somewhat surprising since, even assuming that TMEM59 does not 
participate at all in the regular route, one would expect that its overexpression could 
sequester at least a fraction of the autophagic machinery (the ATG16L1 complex, in this 
case) to cause some depression of the canonical autophagic flux.  Why such an effect (even 
a marginal one) does not occur is unclear, but the notion that separate pools of critical 
effectors (ATG16L1) are involved in different autophagic-like processes might be worth 
considering in future studies.  In any event, such tight segregation between the two 
autophagic events may provide a methodological advantage to clearly show dissociation of 
an atypical autophagic phenomenon from the canonical pathway.  Thus, apart from 
establishing whether or not it involves single membranes (EM) or different autophagic 
machinery (independence of upstream effectors), a routine assay could involve testing a 
possible impact on recognized substrates of canonical autophagy.   
Mammalian ATG16 (ATG16L1) is substantially larger than the yeast ortholog,88 
raising the notion that the molecule has evolved structurally to acquire new functions.  In 
particular, a C-terminal domain containing seven WD40-type repetitions has been added 
during evolution, the function of which has been unclear.  This domain is dispensable for 
conventional autophagy, because a version of ATG16L1 lacking this portion fully sustains 
the pathway in mammalian cells.89  Notably, the ATG16L1-binding motif found in 
TMEM59 recognizes the WD40 domain of ATG16L1, thus ascribing for the first time a 
molecular function to this region.36  Since different versions of the motif are conserved with 
the same ATG16L1-binding functionality in different unrelated proteins,36 the existence of 
a whole family of ATG16L1 adaptors that share this structural feature and engage 
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ATG16L1 in response to different stimuli appears as a likely possibility.  Accessing the 
whole collection of such adaptors would help expand the field of selective autophagy 
against membranous compartments, and might shed light into the role of ATG16L1 in 
some of the non-autophagic biological situations where it has been involved (see below).  
Endogenous TMEM59 mediates the autophagic response triggered by 
Staphylococcus aureus at early infection times when the bacteria are enclosed in single-
membrane phagosomes.36  These data are consistent with a relevant role of ATG16L1 in 
the autophagic burst elicited by bacterial invasion, a notion further underscored by the 
established function of ATG16L1 in the antibacterial activity of NOD1 and 2 (see above).  
In fact, ATG16L1 seems to be important in intestinal homeostasis, a biological 
environment that needs proper management of the bacterial flora naturally inhabiting the 
digestive tract.  This idea was initially suggested by the fact that a polymorphic form of 
ATG16L1 (T300A) increases the risk of suffering Crohn’s disease,48-50 and is further 
supported by the Crohn’s disease-like defects exhibited by Atg16L1-deficient mice.45-47  
Thus, these results point to a relevant role of ATG16L1 in antibacterial immunity, and raise 
the notion that its WD40 domain may have arisen during evolution to fulfill more 
sophisticated autophagic functions that are exclusive of multicellular organisms, like native 
immunity.  More generally, a similar principle may have driven the increased complexity of 
the autophagic machinery that is observed in higher eukaryotes compared to yeast cells, 
with additional ATGs, more ATG isoforms and structural changes in certain ATGs (like 
addition of the WD40 domain in ATG16L1), all of which may have facilitated adaptation 
of the autophagic process to new functions.  Although TMEM59 mediates autophagy 
induced by Staphylococcus aureus, it does not seem to have a general role in autophagy 
directed to bacterial phagosomes, since only an effect during infection with this bacteria, 
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but not other strains, was found (Pimentel-Muiños’ laboratory, unpublished observations).  
Interestingly, TMEM59 was identified in a proteomics study of phagosomes containing 
inert latex beads,90 so the described function in Staphylococcus phagosomes might reflect a 
more general role in vesicle trafficking.   
Entosis constitutes an additional example of single membrane vesicles that become 
labeled with LC3.  This is a specialized form of phagocytosis where whole live cells are 
engulfed by neighboring cells in a striking process that eventually causes non-apoptotic 
death of the internalized cell.91  This phenomenon involves formation of single-membrane 
phagosomes that quickly become LC3-positive independently of conventional 
autophagosomes.33  Thus, no evidence of fusion with autophagic compartments or multiple 
membranes was detected, and labeling with GFP-LC3 was achieved at the expense of the 
diffuse pool of the marker but not preexisting GFP-LC3-positive autophagosomes.  Again, 
this is surprising, since one would expect that engagement of the autophagic machinery by 
the phagosome would at least remove important signaling effectors from the main 
autophagic route.  LC3 recruitment to the phagosome was dependent on PIK3C3, ATG5 
and ATG7, but independent of RB1CC1, suggesting mechanistic differences with canonical 
autophagy and similarities with LAP.  The fact that both LAP and entosis engage the 
autophagic route at the level of BECN1-PIK3C3 suggests that this complex may constitute 
an additional relevant node for selective autophagy of membranous compartments, aside 
from ATG16L1 (see Fig. 1).  Engulfment of apoptotic bodies and macropinosomes trigger 
a similar process.33  Since all these entotic-like, LC3-associated phagocytic events involve 
internalization of self material, it is unlikely that they are triggered by TLR activation, 
suggesting that different initiation events mediate LC3 activation in LAP and entosis.  It 
would be very interesting to know the mechanisms involved in recruitment of the 
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autophagic machinery to the entotic vesicle.  Of note, ATG16L1 has been shown to interact 
with CLATHRIN,21 so a direct interaction between the endocytic and autophagic 
machineries could explain how entotic-like vesicles become LC3-positive.  CLATHRIN 
might, therefore, constitute an additional example of ATG16L1 adaptor (Fig. 1).   
 
Selective autophagic labeling of membrane compartments with unconventional, non-
degradative purposes  
 
From a purely etymological point of view, the processes described in the previous section 
fit into the general category of “autophagy”, since for the most part they result in 
degradation (phagy) of intracellular components (auto) (Figs. 2A and 2B).  However, in 
this section we now include an expanding collection of phenomena where intracellular 
membranes become decorated with LC3 or other autophagic effectors without resulting in 
digestion of the labeled compartment (Figs. 2C and 2D).  Whether or not these constitute 
autophagic processes is debatable, and their recent discovery may invoke the need for a 
more strict definition of what the term autophagy really defines.  As discussed below, some 
of these phenomena may be particularly informative regarding the functional roles of some 
autophagic effectors, LC3 in particular. 
Bacterial phagosomes are in some cases targeted by regular autophagy to produce 
multimembrane LC3-positive compartments that, instead of promoting degradation of the 
invader, appear to provide a niche for bacterial replication (Fig. 2C).60  For example, 
Yersinia resides in autophagosomal, multimembrane, LC3-positive, non-acidic vesicles that 
sustain bacterial proliferation.92,93  In addition, phagosomes containing Staphylococcus 
aureus are surrounded by multiple membranous structures that become LC3-positive 
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around three hours post infection, an autophagic phenomenon that favors replication of the 
pathogen.94  Similarly, Brucella abortus traffics to multimembrane vesicles whose 
formation depends on the upstream autophagic machinery (BECN1, ULK1) but not 
downstream ATGs.  These structures favor cell-to-cell spreading of the bacteria instead of 
its killing.95  Poliovirus utilizes LC3-positive, double membrane vesicles as replication 
sites, and inhibition of the autophagic pathway decreases viral yield.96  Coronaviruses 
assemble their replicative complexes on the surface of double membrane vesicles that 
become decorated with non-lipidated LC3 without the involvement of canonical autophagic 
mediators, and this unconventional LC3 labeling serves viral replication.97   
Single-membrane phagosomes containing a number of bacteria have also been 
shown to acquire autophagic features that promote survival of the enclosed bacterium, 
rather than its elimination (Fig. 2D).  For example, Coxiella burnetii is internalized in a 
spacious phagosome whose maturation is delayed by the bacteria.  This structure ends up 
acquiring autophagic traits that are reminiscent of LAP (decoration with BECN1 and LC3) 
and help increase replication of the pathogen.98,99  Similarly, a fraction of intracellular 
Listeria reside into LC3-positive single-membrane compartments that facilitate its 
proliferation, thus causing persistent infection.100  The mechanisms explaining how these 
single-membrane phagosomes become LC3-positive, and why this process results in 
bacterial survival, remain to be investigated in detail.   
 Examples involving assembly of the autophagic machinery on single-membrane 
structures for additional non-degradative outcomes have recently been described (Fig. 2D), 
and the diversity of processes where this phenomenon has been observed was actually 
unexpected.  For instance, bone resorption entails the localized secretion of lysosomal 
contents through a specialized “ruffled border” of polarized osteoclasts that is apposed to 
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the bone surface, and recent evidence indicates that some autophagic mediators play a 
critical role in this phenomenon.101  Thus, the ruffled border becomes labeled with LC3 in a 
process mediated by conventional autophagic effectors (ATG5, ATG7 or ATG4).  No 
evidence of double membranes was found in this specialized membrane domain, whose full 
maturation actually depends on the autophagic machinery.  The nature of the initiating 
signal that promotes specific LC3 labeling of this region is unknown, but the involvement 
of specific inducers or adaptors that locally engage nodal autophagic mediators appears as a 
plausible mechanism.   
What might be the exact role of LC3 at this location is currently unclear.  However, 
it is tempting to speculate that LC3 labels the ruffled border to promote the directed 
secretion of lysosomal contents.  This possibility would point to a direct role of LC3 in 
promoting fusion with the lysosome that might have remained unidentified in the canonical 
route owing to the critical activities that LC3 plays in previous steps of autophagosomal life 
(membrane elongation and closure, and autophagosome maturation).  A phenomenon that is 
implicitly involved in the autophagic pathway is the final fusion of the mature 
autophagosome with the lysosomal compartment, so it is conceivable that the same 
machinery mediating this final step works in other cellular processes where lysosome 
fusion with membranous structures is also required.33,34,102  This possible function of LC3 is 
particularly well supported by examples where LC3 labeling has unconventional, non-
autophagic outcomes that still require lysosomal delivery, as it happens in osteoclasts. 
The antiviral activity provided by IFNγ during norovirus infection involves a non-
degradative role of the ATG12-ATG5-ATG16L1 complex that was recently identified.103  
This unconventional function proceeds with ATG16L1 localization in membranous 
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structures that lack an obvious resemblance to autophagosomes and provide a niche for 
assembly of the norovirus replication complex.103,104  Although the precise role of 
ATG16L1 at this location remains to be determined, the notion that a specific factor 
recruits this mediator for a non-degradative function is again conceivable. 
A role of some autophagic effectors in secretion processes can be inferred from 
additional recent data.  Single-membrane secretory granules of the neuroendocrine PC12 
cell line stain positive for ATG16L1, and depletion of this effector results in defective 
hormone secretion.105  Since LC3 does not associate with the same granules, the function of 
ATG16L1 is probably unrelated to the orthodox autophagic pathway in this context.  This 
report is in line with a previous one showing that both ATG16L1 hypomorphic mice and 
Crohn’s patients harboring the risk polymorphism ATG16L1-T300A exhibit secretory 
defects in Paneth cells, a specialized intestinal cell that discharges protective peptides to the 
intestinal lumen.45  The defective cells emit less lysozyme and show a hypervacuolated 
cytoplasm owing to a disorganized secretory granule compartment.  Whether or not 
ATG16L1 itself and/or LC3 are present in the secretory vesicles of these cells has not been 
carefully examined, but the phenotype is similar to the one caused by ATG16L1 depletion 
in PC12 cells, so both experimental systems might share the same mechanism to target 
ATG16L1 to the relevant vesicles.  A role of autophagy in the unconventional secretion of 
IL-1β has also recently been proposed.106  Although whether or not this process is linked to 
single-membrane vesicles has not been explored, it does involve colocalization between the 
IL-1β-containing structures and LC3.  The involvement of autophagy in unconventional 
secretion of otherwise cytoplasmic molecules was first described in yeast cells,107,108 
suggesting that this is an evolutionarily conserved process.   
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In a different example, melanosomes are single-membrane vesicles that contain the 
pigment melanin and colocalize with ATG5 and LC3.  In fact, proper function of these 
vacuoles seems to rely on autophagic effectors such as WIPI1, BECN1 or ATG5, as 
revealed by identification of these proteins in a siRNA-based screen for melanosome 
activity.109  What are the mechanisms that promote assembly of the autophagic machinery 
on these membranes is unclear, but the existence of specific inducer molecules encharged 
of this job appears as a likely possibility once again.   
Taken together, the examples mentioned in this section illustrate that intracellular 
membranes appear to constitute common assembly sites for the autophagic machinery to 
carry out biological functions not directly linked to the canonical degradation route.  In 
addition, many of these processes appear to share a common link to vesicle trafficking, a 
finding that may reflect a more general role of the autophagic machinery in this basic 
cellular process.110,111  Since autophagy is, in essence, a vesicular trafficking phenomenon, 
the alternative use of some autophagic effectors in other non-autophagic trafficking events 
is perhaps not surprising.   
 
Summary and perspectives 
 
Here we have reviewed a collection of examples showing that intracellular membranes 
constitute a particularly flexible stage for the action of the autophagic machinery with both 
degradative and non-degradative purposes.  In the most conventional version of the process, 
intracellular vesicles can be subject to canonical autophagic phenomena where the relevant 
vacuole is treated just like any other autophagic substrate, and the end product is a 
multimembrane compartment that eventually undergoes fusion with the lysosome (see Fig. 
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2A).  However, an expanding range of examples show, first, that non-canonical single 
membrane vesicles can be dominantly committed to lysosomal fusion through the action of 
autophagic machinery (Fig. 2B), second, that canonical multimembrane autophagosomes 
may serve non-degradative purposes (Fig. 2C) and, third, that unconventional membranous 
structures often constitute assembly sites for functional autophagic modules that promote a 
wide variety of non-degradative activities (Fig. 2D).  Why intracellular membranes 
constitute such a versatile platform is unclear, but it is conceivable that, in a way, the 
autophagic machinery just represents a subgroup of the membrane trafficking machinery, 
and that all this complexity arises from the intersection between both basic pathways.  A 
few key issues in the field deserve particular attention.  One of them is identification of the 
mechanisms that turn a theoretically degradative compartment into a cozy niche for 
microbial replication/survival.  Reaching a full consensus on whether LC3 labeling of 
single membrane compartments involves fusion with preexisting LC3-positive structures or 
is mainly due to local LC3-II synthesis, is also an important aspect.  We anticipate that 
most of the unconventional processes included here are likely to be regulated by the action 
of molecular adaptors that promote assembly of specific nodal cassettes of the autophagic 
machinery on the relevant membrane sites.  Identification of these adaptors constitutes an 
important and interesting matter.  From the available literature, significant autophagic 
nodes in this context appear to be the BECN1-PIK3C3 and ATG12-ATG5-ATG16L1 
complexes, and perhaps LC3 in some cases like damaged mitochondria (see Fig. 1).  We 
predict that a wide variety of adaptor/inducer molecules able to engage these or other yet to 
be discovered nodal effectors will be identified in the near future.   
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Figure legends 
 
Figure 1.  Relevant nodes of the canonical autophagic pathway that are specifically 
engaged in different modalities of unconventional autophagy against membranous 
compartments.  The canonical autophagic pathway flows from the ULK1-MTOR-RB1CC1 
complex to LC3-II synthesis (horizontal arrows).  The BECN1-PIK3C3-ATG14- complex 
is directly or indirectly activated during LAP and entosis (a).  NODs and TMEM59 (and 
perhaps CLATHRIN) induce the ATG12-ATG5-ATG16L1 complex by interacting with 
ATG16L1 (b).  NIX and PARK2 (through ubiquitination) engage the pathway at the level 
of LC3 (c).  The end result in all cases is LC3 labeling of the targeted membranous 
structure.  
 
Figure 2.  Scheme of the different modalities of autophagy involving membrane 
compartments and their functional consequences (bottom).  (A) Regular, single-membrane 
vesicles are targeted by conventional autophagy to produce multi-membrane vacuoles that 
fuse with lysosomes for degradation of their contents.  (B) Regular, single-membrane 
vesicles become directly labeled with LC3-II and eventually fuse with lysosomes for 
degradation.  (C) Regular, single-membrane vesicles are targeted by conventional 
autophagy producing multi-membrane vacuoles with non-degradative functions.  (D) 
Regular, single-membrane vesicles or other membranous structures become directly labeled 
with LC3-II for a variety of non-degradative functions.  (V: vesicle; MMs: multiple 
membranes; SM: single membrane; L: lysosome).   


